Itron, Inc. (NASDAQ:ITRI – Get Free Report) SVP Christopher Ware sold 763 shares of the company’s stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $100.17, for a total transaction of $76,429.71. Following the completion of the sale, the senior vice president directly owned 31,043 shares of the company’s stock, valued at $3,109,577.31. The trade was a 2.40% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.
Itron Price Performance
Shares of ITRI traded down $4.33 during mid-day trading on Monday, hitting $95.21. The company’s stock had a trading volume of 2,762,408 shares, compared to its average volume of 824,922. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.80 and a quick ratio of 1.56. The firm has a 50-day moving average price of $97.72 and a 200 day moving average price of $109.93. Itron, Inc. has a fifty-two week low of $88.57 and a fifty-two week high of $142.00. The stock has a market capitalization of $4.28 billion, a price-to-earnings ratio of 14.63, a PEG ratio of 0.86 and a beta of 1.48.
Itron (NASDAQ:ITRI – Get Free Report) last released its earnings results on Tuesday, February 17th. The scientific and technical instruments company reported $2.46 EPS for the quarter, beating the consensus estimate of $2.19 by $0.27. The business had revenue of $571.66 million during the quarter, compared to analyst estimates of $561.31 million. Itron had a net margin of 12.72% and a return on equity of 20.04%. The business’s quarterly revenue was down 6.7% on a year-over-year basis. During the same period in the prior year, the business earned $1.35 earnings per share. Itron has set its Q1 2026 guidance at 1.200-1.300 EPS and its FY 2026 guidance at 5.750-6.250 EPS. On average, research analysts predict that Itron, Inc. will post 5.33 EPS for the current fiscal year.
Institutional Investors Weigh In On Itron
Analyst Upgrades and Downgrades
ITRI has been the topic of a number of recent analyst reports. Zacks Research lowered Itron from a “hold” rating to a “strong sell” rating in a research report on Wednesday, January 28th. Johnson Rice upgraded Itron from an “accumulate” rating to a “buy” rating and set a $130.00 price objective on the stock in a report on Monday, January 5th. Stephens raised shares of Itron from an “equal weight” rating to an “overweight” rating and set a $130.00 price objective for the company in a research note on Monday, November 3rd. Weiss Ratings cut shares of Itron from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, January 12th. Finally, Oppenheimer lifted their price objective on shares of Itron from $125.00 to $133.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 18th. Eight analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $137.90.
Get Our Latest Analysis on Itron
More Itron News
Here are the key news stories impacting Itron this week:
- Neutral Sentiment: Itron announced a $600.0 million offering of convertible senior notes — this raises cash but can be dilutive if converted; market reaction depends on use of proceeds and conversion terms. Itron Announces $600.0 Million Convertible Senior Notes
- Negative Sentiment: SVP Christopher E. Ware sold 4,486 shares at ~$99.54 (reducing his stake ~12.36%). Form 4 – Christopher E. Ware
- Negative Sentiment: SVP Donald L. Reeves III sold 5,419 shares at ~$99.54 (reducing his stake ~14.05%). Form 4 – Donald L. Reeves III
- Negative Sentiment: SVP Laurie Ann Pulatie‑Hahn sold 3,755 shares at ~$99.54 (reducing her stake ~10.03%). Form 4 – Laurie Ann Pulatie‑Hahn
- Negative Sentiment: SVP Justin K. Patrick sold 4,930 shares at ~$99.54 (reducing his stake ~12.55%). Form 4 – Justin K. Patrick
- Negative Sentiment: SVP John F. Marcolini sold 6,948 shares at ~$99.54 (reducing his stake ~20.52%). Form 4 – John F. Marcolini
- Negative Sentiment: CFO Joan S. Hooper sold 15,293 shares at ~$99.54 (reducing her stake ~10.96%); a CFO sale of this size is often viewed negatively by investors. Form 4 – Joan S. Hooper
About Itron
Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.
Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.
See Also
- Five stocks we like better than Itron
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.
